0000899243-17-011717.txt : 20170503
0000899243-17-011717.hdr.sgml : 20170503
20170503193844
ACCESSION NUMBER: 0000899243-17-011717
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170503
DATE AS OF CHANGE: 20170503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 167 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6176795500
MAIL ADDRESS:
STREET 1: 167 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZEIN YOUSSEF EL
CENTRAL INDEX KEY: 0001193366
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 17811300
MAIL ADDRESS:
STREET 1: HYBRIDON INC
STREET 2: 345 VASSAR STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals II, L.P.
CENTRAL INDEX KEY: 0001562069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 17811301
BUSINESS ADDRESS:
STREET 1: STARCO CENTER BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT 2020-3313
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 9611363362
MAIL ADDRESS:
STREET 1: STARCO CENTER BLOC B, THIRD FLOOR
STREET 2: OMAR DAOUK STREET
CITY: BEIRUT 2020-3313
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Pharmaceuticals I LP
CENTRAL INDEX KEY: 0001534425
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 17811302
BUSINESS ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 0119611363362
MAIL ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pillar Invest Corp
CENTRAL INDEX KEY: 0001534428
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 17811303
BUSINESS ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
BUSINESS PHONE: 0119611363362
MAIL ADDRESS:
STREET 1: C/O PILLAR INVEST OFFSHORE SAL
STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST
CITY: BEIRUT
STATE: M8
ZIP: 2020-3313
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-01
0
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001534428
Pillar Invest Corp
C/O IDERA PHARMACEUTICALS, INC.
167 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
1
0
0001534425
Pillar Pharmaceuticals I LP
PILLAR INVEST OFFSHORE SAL, STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
1
0
1
0
0001562069
Pillar Pharmaceuticals II, L.P.
PILLAR INVEST OFFSHORE SAL, STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
1
0
1
0
0001193366
ZEIN YOUSSEF EL
PILLAR INVEST OFFSHORE SAL, STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT
M8
2020-3313
LEBANON
1
0
1
0
Common Stock
2017-05-01
4
S
0
41578
2.2591
D
0
I
See footnotes
Common Stock
2017-05-01
4
S
0
409237
2.2591
D
0
I
See footnotes
Common Stock
2017-05-01
4
X
0
409237
0.00
A
0
I
See footnotes
Warrants
0.70
2017-05-01
4
X
0
409237
0.00
D
2012-11-09
2017-11-09
Common Stock
409237
4624824
I
See footnotes
The sales reported in this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Persons.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $2.25-$2.355. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"), of which Pillar Invest Corporation ("Pillar GP") is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. As of the date hereof, Pillar I owns directly 2,090,125 shares of common stock of the Issuer.
Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"), of which Pillar GP is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. As of the date hereof, Pillar II owns directly 6,135,132 shares of common stock of the Issuer.
Youssef El Zein is a director and controlling stockholder of Pillar GP and serves as the representative of a Pillar I, Pillar II and Pillar GP on the Issuer's board of directors. Mr. El Zein disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and Pillar II and this report shall not be deemed an admission that he is the beneficial owners of any such securities, except to the extent of his pecuniary interest therein, if any, by virtue of his ownership interest in Pillar GP. As of the date hereof, Mr. El Zein owns directly 528,538 shares of common stock of the Issuer.
Warrants beneficially owned and exercised for shares of common stock by Pillar II. Pillar GP disclaims Section 16 beneficial ownership of the Warrants and the common stock underlying such warrants and this report shall not be deemed an admission that Pillar GP is the beneficial owner of any such securities, except to the extent of its pecuniary interest therein.
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
2017-05-03
/s/ Youssef El Zein
2017-05-03